CN107095981A - A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia - Google Patents
A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia Download PDFInfo
- Publication number
- CN107095981A CN107095981A CN201710316704.3A CN201710316704A CN107095981A CN 107095981 A CN107095981 A CN 107095981A CN 201710316704 A CN201710316704 A CN 201710316704A CN 107095981 A CN107095981 A CN 107095981A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- hyperlipemia
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating phlegm blockage hyperlipemia, the Chinese medicine composition includes following component in parts by weight:5 15 parts of rhizoma alismatis, 5 10 parts of Cassia occidentalis, 48 parts of the tuber of multiflower knotweed, 48 parts of raw hawthorn, 4 10 parts of marine alga, radix bupleuri(Vinegar is processed)36 parts, 4 10 parts of the red sage root, 13 parts of Herba Lycopi, 35 parts of Poria cocos, 35 parts of method summer, 35 parts of radix glycyrrhizae, 36 parts of rhizoma cyperi, 36 parts of safflower, 46 parts of cattail pollen, 9 12 parts of Snakegourd Fruit, 1.5 3 parts of leech, 6 12 parts of the fruit of Chinese wolfberry, 10 20 parts of coix seed, 6 10 parts of ginkgo.
Description
Technical field
The present invention relates to a kind of Chinese medicine, more particularly, to a kind of Chinese traditional medicine composition for being used to treat phlegm blockage hyperlipemia
Thing.
Background technology
Substantial amounts of basic research data and clinical practice prove that hyperlipemia is disorders of lipid metabolism, are Atherosclerosis
Change the principal element with cardiovascular and cerebrovascular disease.With the continuous improvement of people's living standards, carbohydrate, lipid hyperpyrexia in diet structure
Amount composition increases, and hyperlipemia morbidity is more and more universal, and in the trend that becomes younger.Modern medicine it is studied achieve it is considerable
Progress, but long-term taking Western medicine produce side effect and adverse reaction be always treatment in problem.Though theory of traditional Chinese medical science nothing
The name of disease of hyperlipemia, but the title that can borrow modern medicine is described.The traditional Chinese medical science thinks, the cause of disease of hyperlipemia
The interpretation of the cause, onset and process of an illness is exactly that phlegm is turbid and blood stasis.Hyperlipemia and liver,spleen,kidney three be dirty and gas, blood, phlegm, becomes silted up closely related, and Etiological is this void
Mark is real, and insufficiency of the spleen yang-energy is deficient, or liver kidney deficiency of YIN-blood, accumulates in phlegm wet, qi depression to blood stasis, and phlegm accumulating with stagnant blood, qi and blood is not smooth.From suitable
Traditional Chinese medicine for treating hyperlipidemia disease, not only effect is good, and toxic side effect is small, treats both principal and secondary aspect of disease, patient born pain can also mitigate.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating phlegm blockage hyperlipemia, to improve existing control
It is mostly Western medicine to treat hyperlipemia medicine, and toxic side effect is strong, the technical problem such as course for the treatment of length, cost are high, effect is undesirable.
In order to solve the above-mentioned technical problem, the technical solution adopted by the present invention is:One kind treats phlegm blockage high fat of blood
The Chinese medicine composition of disease, including following component in parts by weight:5-15 parts of rhizoma alismatis, 5-10 parts of Cassia occidentalis, 4-8 parts of the tuber of multiflower knotweed, life
4-8 parts of hawthorn, 4-10 parts of marine alga, radix bupleuri(Vinegar is processed)3-6 parts, 4-10 parts of the red sage root, 1-3 parts of Herba Lycopi, 3-5 parts of Poria cocos, method summer 3-5
Part, 3-5 parts of radix glycyrrhizae, 3-6 parts of rhizoma cyperi, 3-6 parts of safflower, 4-6 parts of cattail pollen, 9-12 parts of Snakegourd Fruit, 1.5-3 parts of leech, fruit of Chinese wolfberry 6-12
Part, 10-20 parts of coix seed, 6-10 parts of ginkgo.
Preferably, the Chinese medicine composition of the treatment phlegm blockage hyperlipemia, including in parts by weight as follows
Component:10 parts of rhizoma alismatis, 5 parts of Cassia occidentalis, 5 parts of the tuber of multiflower knotweed, 5 parts of raw hawthorn, 5 parts of marine alga, radix bupleuri(Vinegar is processed)4 parts, 4 parts of the red sage root, Herba Lycopi 3
Part, 3 parts of Poria cocos, 3 parts of method summer, 3 parts of radix glycyrrhizae, 4 parts of rhizoma cyperi, 3 parts of safflower, 4 parts of cattail pollen, 9 parts of Snakegourd Fruit, 2 parts of leech, the fruit of Chinese wolfberry 10
Part, 15 parts of coix seed, 6 parts of ginkgo.
During the medicine preparation, after above-mentioned each component is weighed by weight, add water to cook three times, directly drink.
In the component of the present invention, rhizoma alismatis is the dry tuber of Notes On Alism At Aceae rhizoma alismatis, and it can influence the decomposition of fat, subtract
The synthesis of few acetyl coenzyme A, so as to influence the synthesis of serum cholesterol, prevents lipoidis from being detained or penetrate into arteries and veins in serum
The ability of wall, promotes the transport and removing of serum cholesterol in blood plasma.Cassia occidentalis is Cassia or the dry mature seed of little Cassia tora,
It is bitter, sweet, salty, with relaxing bowel, lipid-loweringing improving eyesight, sharp water defaecation, the effect of hypotensive.Tuber of multiflower knotweed bitter is dry and astringent, slightly warm in nature, mends
Liver kidney-nourishing, nourishing the blood to expel wind, it has anti-oxidant, anti-aging, enhancing immunity of organisms, treats anaemia, fat-reducing liver-protecting, prevents artery
Atherosis, suppresses the effect of lipid deposition.Raw hawthorn is the fruit of rose vine hawthorn, containing short, bristly hair or beard acid, vitamin C, flavones
Deng composition, with the stagnant helping digestion that disappears, promoting blood circulation and removing blood stasis, effect that the oiling that disappears is greasy, can be depressured, reducing blood lipid, vasodilator, the anti-rhythm of the heart lose
Often, anticancer, raising immunity of organisms, improve internal lipid metabolism, remove the excessive cholesterol of peripheral tissues.Marine alga bitter, salty, tool
There is the effect of softening hard masses, dissolving phlegm, Li Shui, detumescence.Radix bupleuri(Vinegar is processed), vinegar moxibustion radix bupleuri can remove the being slightly cold property of radix bupleuri, and it can soothing the liver reason
Gas, the Xie Yu that expels the heat-evil, liter carry yang-energy, and can make the level of the cholesterol, triglycerides and phosphatide of acceptor significantly reduces, wherein glycerine three
The reduction of fat is particularly evident, and the excretion red sage root that can accelerate cholesterol and its metabolin is traditional activating blood and removing stasis drug, is for many years
The root and rhizome of the raw herbaceous plant red sage root, bitter cold nature, with stasis-dispelling and pain-killing, invigorate blood circulation, relieving restlessness that clears away heart-fire, Apocenosis pain relieving
Effect, the phenolic active components of the red sage root can suppress the activity of the SOD in human erythrocyte, the heart, liver, kidney, play antioxidation.
Herba Lycopi is warm-natured, bitter, there is invigorate blood circulation, inducing diuresis for removing edema.Poria cocos is rich in protein, vitamin A/E, and energy invigorating the spleen is to mend
Spleen controls the common drug of the deficiency of vital energy, can suppress the permeability of capillary, reduces blood glucose, removes interior free yl.The method summer has dry
The pleasant effect of humidifying phlegm, strong spleen.Radix glycyrrhizae is the root and stem of radix glycyrrhizae, and rich in glycyrrhizic acid, it has clearing heat and detoxicating effect, town
Cough phlegm-dispelling functions also fine.Rhizoma cyperi bitter, micro-pungent are sweet, Return liver, the spleen channel, with soothing liver-qi stagnation, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving work(
Effect.The safflower thoughts of returning home, liver two pass through, can invigorate blood circulation, blood stasis removing analgesic, dissipate wet effect going to swell.Cattail pollen acrid-sweet flavor, it is cool in nature, it is the silt that disappears of invigorating blood circulation
Chinese medicine, to reducing blood lipid and atherosclerosis effect very well, it can suppress cholesterol in food by intestinal absorption, to small
Artery has dilating effect, accelerates blood flow, suppresses the formation of thrombus, reduces hematoblastic cohesion.Snakegourd Fruit cures mainly clearing away heat and eliminating phlegm, width
Chest dissipating bind, cough with lung heat, the turbid Huang of phlegm are thick.Leech, taste is salty, hardship, mild-natured, with blood-breaking by silt, resolving mass and swelling, the work(for changing turbid dredging collateral
Effect, the various illnesss of common-use words extravasated blood class.The fruit of Chinese wolfberry is the ripening fruits of matrimony vine, is medicine-food two-purpose food, rich in a variety of amino
The compositions such as acid, glycine betaine, zeaxanthine, physalin, its property is gentle, with good hypoglycemic, Adjust-blood lipid, antioxygen
Effect of change, has good effect to prevention cardiovascular and cerebrovascular disease.Coix seed returns spleen, stomach, Liver Channel, can ooze except spleen is wet, invigorating the spleen stops
Rush down, sharp stomach is subsided a swelling, and commonly using the cholesterol and the content of triglyceride that can be reduced in blood, prevents cardiovascular and cerebrovascular disease
Disease.Ginkgo contains various bioactivators, and it can reduce capillary permeability, and it is thin that removing free radical loses cardiovascular and cerebrovascular endothelium
The toxic action of born of the same parents, improves microcirculation, promotes heart and brain cell metabolism, can effectively reduce cholesterol and triglycerides, beta lipoprotein
Hdl concentration is improved simultaneously, blood viscosity is reduced, and is suppressed platelet aggregation and thrombosis, is good reducing blood lipid
Medicine.
The Chinese medicine composition of the treatment phlegm blockage hyperlipemia, reasonable selection Chinese medicine composition is fundamentally right
The constitution of patient is nursed one's health, and eliminating the phlegm lipid-loweringing influences the metabolism of lipid from rhizoma alismatis, raw hawthorn, red sage root etc.;It is promoting blood circulation and removing blood stasis to select
Herba Lycopi, leech, safflower etc., liver-kidney tonifying, suppression absorption of lipids are from the tuber of multiflower knotweed, the fruit of Chinese wolfberry, Cassia occidentalis etc., the energy such as cattail pollen, radix bupleuri
Suppress platelet aggregation.The rational compatibility of each component, the maximized effect for playing each component of energy, therapeutic effect is good, can contract
Short treatment cycle, improves therapeutic effect, mitigates patient body burden and economic pressures, therefore the present invention has economic effect well
Benefit and social benefit.
Embodiment
Below in conjunction with specific embodiment, technical scheme is clearly and completely described, it is clear that retouched
The embodiment stated is only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, sheet
The every other embodiment that field those of ordinary skill is obtained under the premise of creative work is not made, belongs to the present invention
The scope of protection.
Embodiment 1:Treat the Chinese medicine composition of phlegm blockage hyperlipemia, including following component in parts by weight:
5-15 parts of rhizoma alismatis, 5 parts of Cassia occidentalis, 4 parts of the tuber of multiflower knotweed, 4 parts of raw hawthorn, 4 parts of marine alga, radix bupleuri(Vinegar is processed)3 parts, 4 parts of the red sage root, 1 part of Herba Lycopi,
3 parts of Poria cocos, 3 parts of method summer, 3 parts of radix glycyrrhizae, 3 parts of rhizoma cyperi, 3 parts of safflower, 4 parts of cattail pollen, 9 parts of Snakegourd Fruit, 1.5 parts of leech, 6 parts of the fruit of Chinese wolfberry,
10 parts of coix seed, 6 parts of ginkgo.
Embodiment 2:The Chinese medicine composition of the treatment phlegm blockage hyperlipemia, including in parts by weight such as the following group
Point:10 parts of rhizoma alismatis, 5 parts of Cassia occidentalis, 5 parts of the tuber of multiflower knotweed, 5 parts of raw hawthorn, 5 parts of marine alga, radix bupleuri(Vinegar is processed)4 parts, 4 parts of the red sage root, Herba Lycopi 3
Part, 3 parts of Poria cocos, 3 parts of method summer, 3 parts of radix glycyrrhizae, 4 parts of rhizoma cyperi, 3 parts of safflower, 4 parts of cattail pollen, 9 parts of Snakegourd Fruit, 2 parts of leech, the fruit of Chinese wolfberry 10
Part, 15 parts of coix seed, 6 parts of ginkgo.
Embodiment 3:15 parts of rhizoma alismatis, 10 parts of Cassia occidentalis, 8 parts of the tuber of multiflower knotweed, 8 parts of raw hawthorn, 10 parts of marine alga, radix bupleuri(Vinegar is processed)6 parts,
10 parts of the red sage root, 3 parts of Herba Lycopi, 5 parts of Poria cocos, 5 parts of method summer, 5 parts of radix glycyrrhizae, 6 parts of rhizoma cyperi, 6 parts of safflower, 6 parts of cattail pollen, 12 parts of Snakegourd Fruit, water
3 parts of leech, 12 parts of the fruit of Chinese wolfberry, 20 parts of coix seed, 10 parts of ginkgo.
The preparation method of Chinese medicine composition for treating phlegm blockage hyperlipemia is:Component weigh it is accurate after, add water
Three times, the weight and the weight ratio of Chinese medicine that three times add water are 9:1、9:1、7:1 decocts into decoction, directly drinks, and daily three
It is secondary.
Component and marketed drugs from embodiment 2 carry out contrast experiment:
Curative effect is carried out from medicine prepared by technical solution of the present invention, 150 hyperlipemias of certain county people's hospital are chosen
Patient is verified that patient age 23-70 Sui is divided into three groups, every group of 50 people.Blood vessels recovering capsule, embodiment 2 is taken respectively to prepare
Medicine and placebo, take within one day three times, continuous use one month.The result is as follows:
Distinguish | Blood vessels recovering capsule group | 2 groups of embodiment | Placebo |
Total effective rate | 87% | 94% | 31% |
By above treatment results it can be found that the Chinese medicine composition of the treatment phlegm blockage hyperlipemia can be reduced well
Serum cholesterol, triglycerides, total effective rate are better than commercially available prod.
Finally it is pointed out that above embodiment is only the more representational example of the present invention.Obviously, it is of the invention
Above-mentioned embodiment is not limited to, there can also be many deformations.Every technical spirit according to the present invention specific reality to more than
Any simple modification, equivalent variations and modification that the mode of applying is made, are considered as belonging to protection scope of the present invention.
Claims (2)
1. a kind of Chinese medicine composition for treating phlegm blockage hyperlipemia, it is characterized in that the Chinese medicine composition is included with parts by weight
The following component of meter:5-15 parts of rhizoma alismatis, 5-10 parts of Cassia occidentalis, 4-8 parts of the tuber of multiflower knotweed, 4-8 parts of raw hawthorn, 4-10 parts of marine alga, radix bupleuri(Vinegar
Process)3-6 parts, 4-10 parts of the red sage root, 1-3 parts of Herba Lycopi, 3-5 parts of Poria cocos, 3-5 parts of method summer, 3-5 parts of radix glycyrrhizae, 3-6 parts of rhizoma cyperi, safflower 3-6
Part, 4-6 parts of cattail pollen, 9-12 parts of Snakegourd Fruit, 1.5-3 parts of leech, 6-12 parts of the fruit of Chinese wolfberry, 10-20 parts of coix seed, 6-10 parts of ginkgo.
2. the Chinese medicine composition for the treatment of phlegm blockage hyperlipemia according to claim 1, it is characterized in that the Chinese medicine group
Compound includes following component in parts by weight:10 parts of rhizoma alismatis, 5 parts of Cassia occidentalis, 5 parts of the tuber of multiflower knotweed, 5 parts of raw hawthorn, 5 parts of marine alga, bavin
Recklessly(Vinegar is processed)4 parts, 4 parts of the red sage root, 3 parts of Herba Lycopi, 3 parts of Poria cocos, 3 parts of method summer, 3 parts of radix glycyrrhizae, 4 parts of rhizoma cyperi, 3 parts of safflower, 4 parts of cattail pollen,
9 parts of Snakegourd Fruit, 2 parts of leech, 10 parts of the fruit of Chinese wolfberry, 15 parts of coix seed, 6 parts of ginkgo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316704.3A CN107095981A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316704.3A CN107095981A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107095981A true CN107095981A (en) | 2017-08-29 |
Family
ID=59668745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710316704.3A Pending CN107095981A (en) | 2017-05-08 | 2017-05-08 | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107095981A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167973A (en) * | 2007-10-26 | 2008-04-30 | 马万凯 | Traditional Chinese medicine for treating hyperlipemia |
CN102000299A (en) * | 2010-11-09 | 2011-04-06 | 赵晓红 | Medicine for treating hyperlipidaemia |
CN102106957A (en) * | 2011-03-24 | 2011-06-29 | 于庆德 | Chinese medicinal composition for treating hyperlipidemia |
CN102961523A (en) * | 2012-10-26 | 2013-03-13 | 郗光敏 | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
CN103432391A (en) * | 2013-08-30 | 2013-12-11 | 董中影 | Medicament for treating hyperlipemia and preparation method thereof |
CN103463426A (en) * | 2013-09-03 | 2013-12-25 | 陈柏林 | Traditional Chinese medicine pill for treating hyperlipidemia |
CN104642618A (en) * | 2013-11-17 | 2015-05-27 | 王俊梅 | Tea for patients with hyperlipidemia |
CN104971300A (en) * | 2014-04-09 | 2015-10-14 | 刘黎明 | Pharmaceutical composition for treating hyperlipidemia due to internal retention of phlegm and dampness |
-
2017
- 2017-05-08 CN CN201710316704.3A patent/CN107095981A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167973A (en) * | 2007-10-26 | 2008-04-30 | 马万凯 | Traditional Chinese medicine for treating hyperlipemia |
CN102000299A (en) * | 2010-11-09 | 2011-04-06 | 赵晓红 | Medicine for treating hyperlipidaemia |
CN102106957A (en) * | 2011-03-24 | 2011-06-29 | 于庆德 | Chinese medicinal composition for treating hyperlipidemia |
CN102961523A (en) * | 2012-10-26 | 2013-03-13 | 郗光敏 | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
CN103432391A (en) * | 2013-08-30 | 2013-12-11 | 董中影 | Medicament for treating hyperlipemia and preparation method thereof |
CN103463426A (en) * | 2013-09-03 | 2013-12-25 | 陈柏林 | Traditional Chinese medicine pill for treating hyperlipidemia |
CN104642618A (en) * | 2013-11-17 | 2015-05-27 | 王俊梅 | Tea for patients with hyperlipidemia |
CN104971300A (en) * | 2014-04-09 | 2015-10-14 | 刘黎明 | Pharmaceutical composition for treating hyperlipidemia due to internal retention of phlegm and dampness |
Non-Patent Citations (6)
Title |
---|
秦雪玲: "《通络降脂汤治疗高血脂症30例》", 《内蒙古中医药》 * |
童蓓丽: "化痰降脂活血汤治疗高脂血症56例", 《陕西中医》 * |
解志坚: "降脂胶囊治疗老年高血脂症疗效观察", 《现代中西医结合杂志》 * |
郑辉: "浅谈高脂血症的辨治", 《湖北中医杂志》 * |
陈汉阳: "中西医结合治疗高血脂症研究进展", 《现代中西医结合杂志》 * |
饶洪: "首乌山楂降脂丸治疗高脂血症临床研究", 《中医学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106754023A (en) | A kind of hawthorn health-care wine of pressure-lowering and blood-activing and preparation method thereof | |
CN104587194A (en) | Yin-nourishing and lung-moistening traditional Chinese medicine composition as well as preparation method and application thereof | |
CN107213451A (en) | Improve probiotics fermention Chinese medicine preparation of microcirculation in human body obstacle and preparation method thereof | |
CN104825801A (en) | TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases | |
CN108159363A (en) | Liver cancer healing liquid and preparation method thereof | |
CN103549437B (en) | Health-protection food capable of reducing blood pressure and blood fat and preparation method of food | |
CN103908652A (en) | Lavipeditum traditional Chinese medicine for treating insomnia and preparation method thereof | |
CN107095981A (en) | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia | |
CN106668633A (en) | Pleione bulbocodioides lipid-eliminating formula | |
CN103494948B (en) | A kind of Chinese herbal medicine for the treatment of hypertension | |
CN105878644A (en) | Medicinal liquor as well as preparation method and use thereof | |
CN108690775B (en) | Production method of health-preserving and health-care white spirit, health-preserving and health-care white spirit and use method thereof | |
CN104997956A (en) | Behcet's syndrome and treatment drug thereof | |
CN105394281A (en) | Health-care plantain seed tea capable of relaxing bowels and moistening intestines | |
CN104645150A (en) | Chinese medicinal extract for soothing liver and regulating qi as well as preparation method and application of Chinese medicinal extract and liver soothing and qi regulating cream | |
CN110731508A (en) | Preparation method of traditional Chinese medicine food for enhancing human immunity and product | |
CN112823804A (en) | Snow pear paste and preparation method thereof | |
CN110229732A (en) | A kind of alcoholic drink mixed with fruit juice and preparation method thereof | |
CN103525642A (en) | Formula of spleen-tonifying and qi-benefiting black sesame wine and production method thereof | |
CN104258143B (en) | Traditional Chinese medicine for treating depressive psychosis caused by vital energy and phlegm stagnation | |
CN107625915A (en) | A kind of Hyssopus officinalis ointment and preparation method thereof | |
CN101596299A (en) | A kind of Chinese medicine pill for the treatment of precancerous lesions of chronic atrophic gastritis | |
CN105362940A (en) | Hypolipidemic cholesterol-reducing healthcare oral solution and preparation method thereof | |
CN104740478A (en) | Traditional Chinese medicine pill for emergency treatment of alcoholism and preparation method thereof | |
CN105456859A (en) | Traditional Chinese medicine for treating phthisis and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170829 |